This medical video focuses on the new technology available to be able to shrink breast tumors.
Read the full transcript »
Jennifer Matthews: Diagnosed with breast cancer five years ago, Theresa Benton still struggles with the disease. Theresa Benton: I just had my mammogram. So I was clear for a year and I just found this little spot, and I said, let me just go let the doctor check it. Jennifer Matthews: The cancer returned in Theresa's lungs. She came to Duke University to join a clinical trial on a new drug called Lapatinib. Dr. Kimberly Blackwell: This drug specifically targets aspects of cancer cells, and shuts them down and in shutting them down hopefully kills them. Jennifer Matthews: X-rays show the drug was able to shrink tumors in some patients. Doctor Blackwell says Lapatinib is a potentially more effective therapy than Herceptin, the frontline drug used for breast cancer treatment. Dr. Kimberly Blackwell: The hypothesis of the trial is that by targeting two proteins we might be able to turn off the cancerous growth, whereas it had started to grow with the drug Herceptin that only targeted one of the proteins. Jennifer Matthews: Theresa was diagnosed at 29. She cautions women to be vigilant about monthly self-breast exams. Theresa Benton: People say, well breast cancer doesn't run in my family, so I don't have to worry about it and they are so, so wrong. So it didn't run in my family either. Jennifer Matthews: Now, Theresa hopes this drug will keep her cancer away for good. This is Jennifer Matthews reporting.